In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials

The cost of clinical trials is ever-increasing. In-silico trials rely on virtual populations and interventions simulated using patient-specific models and may offer a solution to lower these costs. We present the flow diverter performance assessment (FD-PASS) in-silico trial, which models the treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarrami-Foroushani, Ali, Lassila, Toni, MacRaild, Michael, Asquith, Joshua, Roes, Kit C. B., Byrne, James V., Frangi, Alejandro F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222326/
https://www.ncbi.nlm.nih.gov/pubmed/34162852
http://dx.doi.org/10.1038/s41467-021-23998-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222326/
https://www.ncbi.nlm.nih.gov/pubmed/34162852
http://dx.doi.org/10.1038/s41467-021-23998-w

Ejemplares similares